Illumina Investor
Illumina is an innovative technology and revolutionary assays aiming the analyze genetic variation and function.
Invests into
![NALEJ /knowledge [nal-ej]/ Corporation](/storage/logos_100px/nalej.png)
Investors
Technology:
Neurological Disorders
Industry:
AI
Headquarters:
San Diego, California, United States
Founded Date:
1998-01-01
Employees Number:
5001-10000
Funding Status:
IPO
Investor Type:
Accelerator
Investment Stage:
Early Stage Venture, Late Stage Venture
Number Of Exits:
7
Acquisitions Number:
Made Acquisitions
Investors Number:
9
Total Funding:
778000000
Estimated Revenue:
$500M to $1B
Last Funding Date:
2023-01-04
Last Funding Type:
Post-IPO Debt
Register and Claim Ownership